Heat Shock Protein HSP90 Alpha: A Potential Drug Target (G664618)

Target Name: HSP90AB4P

NCBI ID: G664618

HSP90AB4P

Other Name(s): Heat shock protein 90 alpha family class B member 4, pseudogene | HSP90Bd | heat shock protein 90 alpha family class B member 4, pseudogene

Heat Shock Protein HSP90 Alpha: A Potential Drug Target

Heat shock protein 90 alpha (HSP90伪) is a protein that is expressed in various cell types and is involved in a variety of cellular processes. HSP90伪 has been identified as a potential drug target due to its role in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The HSP90伪 protein is composed of 90 amino acid residues and has a calculated molecular weight of 11.9 kDa. It is a member of the HSP90伪 gene family, which is a family of proteins that are involved in the regulation of thermal stability and stress responses. The HSP90伪 gene is located on chromosome 16 and has four exons.

HSP90伪 is expressed in various cell types, including eukaryotic cells, bacteria, and yeast. It is involved in a variety of cellular processes, including DNA replication, transcription, and translation. HSP90伪 has been shown to play a role in the regulation of gene expression and has been linked to various cellular processes, including the regulation of cell growth, apoptosis, and stress responses.

One of the key functions of HSP90伪 is its ability to form a stable complex with other proteins, including transcription factors, DNA-binding proteins, and metal ions. This complex is known as the HSP90伪-associated protein complex (HSP90伪-ASP) and is composed of various proteins that work together to regulate gene expression and cellular processes.

HSP90伪 has been shown to play a role in a variety of diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, HSP90伪 has been shown to be involved in the development and progression of cancer, including breast cancer and colon cancer. It has also been linked to a variety of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its role in disease, HSP90伪 has also been identified as a potential drug target. The HSP90伪-ASP complex has been shown to play a role in the regulation of cellular processes and has been linked to various cellular signaling pathways. As a result, HSP90伪 has been identified as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the potential advantages of targeting HSP90伪 is its ability to be expressed and translated into a variety of proteins, including enzymes, transcription factors, and signaling proteins. This makes it a potentially attractive target for drugs that can modulate its activity and activity levels. Additionally, HSP90伪 has been shown to be involved in a variety of cellular processes, including DNA replication, transcription, and translation, which makes it a potentially attractive target for drugs that can modulate these processes.

In conclusion, HSP90伪 is a protein that is involved in a variety of cellular processes and has been identified as a potential drug target for a variety of diseases. Its ability to form a stable complex with other proteins and its involvement in various cellular processes make it a potentially attractive target for drugs that can modulate its activity and activity levels. Further research is needed to fully understand the role of HSP90伪 in disease and to develop effective drugs that can target its activity.

Protein Name: Heat Shock Protein 90 Alpha Family Class B Member 4, Pseudogene

Functions: Putative molecular chaperone that may promote the maturation, structural maintenance and proper regulation of specific target proteins

The "HSP90AB4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSP90AB4P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets